The DOI matches its Crossref record.
Antimicrobial peptides: The ancient arm of the human immune system
Open accessAbstract
The production of peptides and small proteins with microbicidal activity collectively called antimicrobial peptides (AMPs) is commonly considered to be a primitive mechanism of immunity and has been extensively studied in insects and other non-vertebrate organisms. In addition, a variety of AMPs present in amphibian skin secretion has been well characterised. There is now increasing evidence that AMPs play a crucial role in human immunity as well. Virtually all human tissues and cells typically exposed to microbes are able to produce AMPs. Important AMPs belonging to two structurally distinct classes, known as the defensins and the cathelicidins, are mainly produced by epithelial cells and neutrophils. AMPs significantly contributing to the chemical skin barrier are represented by dermcidin, psoriasin and RNase 7. The antimicrobial activity of saliva largely depends on histidine-rich AMPs known as histatins. Many more, in part less well-known AMPs and AMP-like proteins exist that exhibit various additional functions, apart from their antimicrobial properties. Among them, the neutrophil granule proteins azurocidin and cathepsin G are members of a family of serine-protease homologues called serprocidins and play a role in the regulation of the immune response and degradation of extracellular matrix proteins respectively. As another AMP-like protein of the neutrophil granule content, bactericidal/permeability increasing protein (BPI) is both able to permeabilise bacterial membranes and to function as an opsonin. The whey acidic protein (WAP) domain containing class of AMPs, including secretory leukocyte protease inhibitor (SLPI), elafin and trappin-2, is equally important in inhibition of neutrophil serine proteases and killing of microbes. Certain CC or CXC chemokines are known to possess antimicrobial properties and therefore are called kinocidins. Several kinocidins, including thrombocidin-1 and -2, are contained in the α-granules of platelets. A cytoplasmic AMP described as ubiquicidin turned out to be identical with the strongly basic ribosomal protein S30. Proteolytic cleavage of the histone protein H2A in the stomach gives rise to an AMP initially described as buforin I. Adrenomedullin is a hormone-like AMP exhibiting vasodilatory and hypotensive effects. Lysozyme is mainly known for its cell wall degrading activity, but is also capable of non-enzymatic killing of bacteria. An iron-binding protein present in milk and other secretions named lactoferrin was shown to possess antimicrobial and antiviral activity and has been implicated in protection against cancer. Clinical studies on the treatment of infectious diseases have been performed with artificial peptides derived from human lactoferrin, histatins and BPI in addition to porcine protegrins, frog magains and bovine indolicidin. Omiganan, representing an indolicidin derivative, has been demonstrated to be effective in the treatment of acne and catheter-related local infections and is currently considered to be the most promising AMP-based drug candidate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
Role of lipids in the interaction of antimicrobial peptides with membranes
Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692
An Overview of the Immunological Defenses in Fish Skin
Ángeles Esteban, M. (2012) · ISRN Immunology · doi:10.5402/2012/853470 · Cited by 691
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Platelet-Rich Plasma: A Milieu of Bioactive Factors
Boswell, S. G., Cole, B. J., Sundman, E. A., Karas, V., & Fortier, L. A. (2012) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2011.10.018 · Cited by 613
Zhang, D., de Souza, R. F., Anantharaman, V., Iyer, L. M., & Aravind, L. (2012) · Biology Direct · doi:10.1186/1745-6150-7-18 · Cited by 515
Lactoferrin: Structure, function, denaturation and digestion
Wang, B., Timilsena, Y. P., Blanch, E., & Adhikari, B. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1381583 · Cited by 514
Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny
Kollmann, T. R., Kampmann, B., Mazmanian, S. K., Marchant, A., & Levy, O. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.009 · Cited by 478
The antimicrobial protection hypothesis of Alzheimer’s disease
Moir, R. D., Lathe, R., & Tanzi, R. E. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3040 · Cited by 456
Ramirez, J. L., Souza-Neto, J., Torres Cosme, R., Rovira, J., Ortiz, A., Pascale, J. M., & Dimopoulos, G. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001561 · Cited by 412
Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria
Moravej, H., Moravej, Z., Yazdanparast, M., Heiat, M., Mirhosseini, A., Moosazadeh Moghaddam, M., & Mirnejad, R. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0392 · Cited by 410
Platelet Rich Plasma: a short overview of certain bioactive components
Pavlovic, V., Ciric, M., Jovanovic, V., & Stojanovic, P. (2016) · Open Medicine · doi:10.1515/med-2016-0048 · Cited by 405
Antimicrobial Peptides: Old Molecules with New Ideas
Nakatsuji, T., & Gallo, R. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.387 · Cited by 394
Said, H. S., Suda, W., Nakagome, S., Chinen, H., Oshima, K., Kim, S., Kimura, R., Iraha, A., Ishida, H., Fujita, J., et al. (2014) · DNA Research · doi:10.1093/dnares/dst037 · Cited by 394
Microbial Symbiosis with the Innate Immune Defense System of the Skin
Gallo, R. L., & Nakatsuji, T. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.182 · Cited by 387
Otto, M. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0023-2018 · Cited by 381
Salivary Defense Proteins: Their Network and Role in Innate and Acquired Oral Immunity
Fábián, T. K., Hermann, P., Beck, A., Fejérdy, P., & Fábián, G. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13044295 · Cited by 348
Biological functions of tear film
Pflugfelder, S. C., & Stern, M. E. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108115 · Cited by 340
Antimicrobial peptides and gut microbiota in homeostasis and pathology
Ostaff, M. J., Stange, E. F., & Wehkamp, J. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201773 · Cited by 329
Tear analysis in ocular surface diseases
Zhou, L., & Beuerman, R. W. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.06.002 · Cited by 318
Immunomodulatory effects of lactoferrin
Siqueiros-Cendón, T., Arévalo-Gallegos, S., Iglesias-Figueroa, B. F., García-Montoya, I. A., Salazar-Martínez, J., & Rascón-Cruz, Q. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.200 · Cited by 316
From pathogenesis of acne vulgaris to anti-acne agents
Cong, T.-X., Hao, D., Wen, X., Li, X.-H., He, G., & Jiang, X. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01908-x · Cited by 315
Antimicrobial peptides: Structure, mechanism, and modification
Chen, N., & Jiang, C. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115377 · Cited by 279
Zharkova, M. S., Orlov, D. S., Golubeva, O. Y., Chakchir, O. B., Eliseev, I. E., Grinchuk, T. M., & Shamova, O. V. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00128 · Cited by 272
Kumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107087 · Cited by 272
The skin microbiome: Current perspectives and future challenges
Chen, Y. E., & Tsao, H. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.01.016 · Cited by 268
Diversity, evolution and medical applications of insect antimicrobial peptides
Mylonakis, E., Podsiadlowski, L., Muhammed, M., & Vilcinskas, A. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0290 · Cited by 254
Self-citationFournière, M., Latire, T., Souak, D., Feuilloley, M. G. J., & Bedoux, G. (2020) · Microorganisms · doi:10.3390/microorganisms8111752 · Cited by 227
Legrand, D. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-056 · Cited by 193
Monick, M. M., Baltrusaitis, J., Powers, L. S., Borcherding, J. A., Caraballo, J. C., Mudunkotuwa, I., Peate, D. W., Walters, K., Thompson, J. M., Grassian, V. H., et al. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1206004 · Cited by 37
Metadata
- Authors
- Wiesner, J., & Vilcinskas, A.
- Venue
- Virulence
- Publisher
- Informa UK Limited
- Published
- 2010-09
- Volume
- 1
- Issue
- 5
- Pages
- 440-464
- ISSN
- 2150-5594 (ISSN-L)
- 2150-5608
- OpenAlex
- W1963591185
- Cited by
- 684
- References
- 0
- FWCI
- 44.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.